Greatbatch, Inc. to Present at the Canaccord Adams Cardiovascular Conference on November 10, 2009
* Reuters is not responsible for the content in this press release.
CLARENCE, N.Y.--(Business Wire)-- Greatbatch, Inc. (NYSE: GB) will present at the Canaccord Adams Cardiovascular Conference on November 10, 2009. Thomas J. Hook, President and CEO, will address the conference at 6:00 p.m. E.T. The presentation will be webcast live on the company's Investor Relations website at: www.greatbatch.com. About Greatbatch, Inc. Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long lasting performance through its brands Greatbatch Medical and Electrochem. Greatbatch Medical develops and manufactures critical technologies used in medical devices for the cardiac rhythm management, neuromodulation, vascular access and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the Energy, Military, Portable Medical, and other markets. Additional information about the Company is available at www.greatbatch.com. Greatbatch, Inc. Marco F. Benedetti, 716-759-5856 Corporate Controller & Treasurer mbenedetti@greatbatch.com Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters